WEE1 and cancer: Structural cardiotoxicity can occur with a wide range of drugs and is a concern with several classes of anti-cancer agents ranging from classical chemotherapy agents such as anthracyclines, to the more modern molecular targeted therapy aimed at inhibiting specific protein kinases that play a role in cell proliferation in cancer cells (46).